Erbi Biosystems Breez micro-bioreactor

Monday, 12 December, 2022 | Supplied by: Merck Pty Ltd


Erbi Biosystems is the developer of the 2 mL Breez micro-bioreactor — a micro-scale, fully automated, functionally closed and continuous perfusion cell culture platform.

The product is claimed to transform continuous process development through automation, increasing operator throughput by up to four times compared to other benchtop-scale systems to yield high-performing continuous processes that should lower the cost of manufacturing and increase speed to market. Compared to competitive bioreactor platform technologies, it is said to require less bench space and no biosafety hood.

Online: www.sigmaaldrich.com/AU/en
Phone: 1800 800 097
Related Products

Beckman Coulter Life Sciences Basophil Activation Test (BAT) for food allergy research

Beckman Coulter Life Sciences introduces its next-generation Basophil Activation Test (BAT) to...

TopoGEN Topoisomerase Assay Kits

TopoGEN provides innovative reagents and kits for topoisomerase research and mechanism-based drug...

Alamar Biosciences NULISAseq Mouse Panel 120 for protein biomarker analysis

The multiplex panel encompasses a wide selection of proteins essential for studying key...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd